市場調査レポート - 167162

癌治療薬パイプラインにおけるB細胞受容体シグナル伝達経路

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013

発行 BioSeeker Group AB
出版日 ページ情報 英文  
価格
癌治療薬パイプラインにおけるB細胞受容体シグナル伝達経路 B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013
出版日: 2013年04月22日 ページ情報: 英文
概要

現在、145の企業およびパートナーが癌に関する540の開発プロジェクトの中の190のB細胞受容体経路を標的とした薬剤開発に取り組んでいます。さらに、これまでに中止された薬剤の累積数は66に上っています。

当レポートでは、これらの開発中の薬剤のひとつひとつを分析し、標的、開発段階などに分類し、機序、適応などのそれぞれの薬剤プロファイルをまとめ、概略下記の構成でお届けいたします。

※本商品はCD−ROMにてご提供するデータベースアプリケーションです。ご利用には御客様のパソコン上にアプリケーションをインストールして頂く事が必要となります。

治験責任医師

薬剤名および異名

  • 商標名
  • ジェネリック薬
  • コードネーム

開発段階

  • 540の開発プロジェクトにおける開発中の190の薬剤最新動向
    • 上市済み
    • 登録前
    • 第3相
    • 第2相
    • 第1相
    • 前臨床
    • データなし
    • 中断
    • 中止

適応

標的

  • 120の標的を36に分類

標的発現プロファイル

経路

機序

化合物

薬剤プロファイル

  • 薬剤名
  • 治験担当医師およびパートナー
  • 標的および標的の分子機能
  • 標的の部位
  • 標的経路
  • 機序
  • 開発プロジェクト
  • 薬剤解説
  • 化合物データ
  • 特許データ
  • ビジネスおよび市場
  • 第3相データ
  • 第2相データ
  • 第1相データ
  • 臨床前データ
  • ライセンシング情報

応用特性

システム要件

  • AMD-Athlon/Pentium II PC
  • Windows 98/NT4/2000/ME/XP/VISTA/Windows 7
  • 8x-speed CD Rom drive
  • SVGA 16 bit display. (32 bit recommended)
  • 32 MB of available RAM (128 MB recommended)
  • Browser Application (Internet Explorer, Firefox)
  • Internet access (for related internet resources)

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Abstract

Executive Summary

BioSeeker Group have identified 172 companies plus partners who are today developing 227 B cell receptor pathway targeting drugs in 724 developmental projects in cancer across 148 different targets. In addition, there are 3 suspended drugs and another 88 drugs where development has been ceased.

For busy executives within Pharma, Biotech and Investment companies who know they need to stay on top of the developmental environment in their field, we offer the Drug Pipeline update series.

You get detailed, world-wide drug pipeline information, delivered in an unbiased and independent pipeline progress analysis for each identified drug.

Buying the B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2012 will mean you have this important data at your fingertips and ensure that you can:

  • Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
  • Find competitors, collaborations partners, M&A candidates etc. and track them by their products.
  • Jump start competitive drug intelligence operations
  • Benchmark your own development against world wide data
  • Compare portfolio and therapy focus with your peers
  • Speed up pro-active in-/outlicensing strategy work

Some facts about B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2012

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-receptor tyrosine kinases including those of the Src, Tec and Syk family of kinases. Downstream messengers include DAG, IP3, MAPK/ERK and JNK signaling modules.

There are today 172 companies plus partners developing 227 B cell receptor pathway targeting drugs in 724 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 88 drugs. B Cell Receptor Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 148 different targets. These targets are further categorized on in the software application by 39 classifications of molecular function and with pathway referrals to BioCarta, KEGG and NetPath.

Table of Contents

This short overview shows actual findings from the B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2012 report.

This short overview shows actual findings from the B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2012 report.

Investigators

Includes more than 172 principal investigators plus their collaborators. There is direct access from inside the application to web pages of all principal investigators.

Note: You are able to sort and find drugs according to investigators and partners from drop-down menus in the application. You may also sort and find drugs according to country of investigator.

Drug name & Synonyms

Lists commercial, generic and code names for drugs.

Developmental stage

This Drug Pipeline Update contains 227 B cell receptor pathway targeting drugs in development, which have a total of 724 developmental projects in cancer. In addition there are suspended and ceased drugs.

Pipeline Breakdown According to Number of Drugs:

  • Marketed# 11
  • Registered# 1
  • Pre-registration# 2
  • Phase III# 12
  • Phase II# 63
  • Phase I# 90
  • Preclinical# 151
  • No Data# 2
  • Suspended# 3
  • Ceased# 88

Note: You are able to sort and find drugs according to developmental stage from drop-down menu in the application.

Indications

Included B cell receptor pathway targeting drugs are also in development for 122 other indications, where of 66 are different cancer indications.

Note: You are able to find and sort drugs according to type of indication from drop-down menu in the application.

Targets

Identified drugs are linked to more than 148 different targets, divided into 39 classifications of molecular function:

  • ATPase activity
  • B cell receptor activity
  • Catalytic activity
  • Cell adhesion molecule activity
  • Chemokine activity
  • Cysteine-type peptidase activity
  • Cytokine activity
  • DNA binding
  • DNA repair protein
  • DNA topoisomerase activity
  • G-protein coupled receptor activity
  • Glutathione transferase activity
  • Growth factor activity
  • GTPase activity
  • Kinase activity
  • Kinase binding
  • Kinase regulator activity
  • Lipid kinase activity
  • Lipid phosphatase activity
  • Molecular function unknown
  • Oxidoreductase activity
  • Peroxidase activity
  • Protein binding
  • Protein serine/threonine kinase activity
  • Protein threonine/tyrosine kinase activity
  • Protein tyrosine phosphatase activity
  • Protein tyrosine/serine/threonine phosphatase activity
  • Protein-tyrosine kinase activity
  • Receptor activity
  • Receptor signaling complex scaffold activity
  • Receptor signaling protein serine/threonine kinase activity
  • Serine-type peptidase activity
  • Structural constituent of cytoskeleton
  • Transcription factor activity
  • Transcription regulator activity
  • Translation regulator activity
  • Transmembrane receptor activity
  • Transmembrane receptor protein tyrosine kinase activity
  • Transporter activity

Identified targets are categorized into 26 different primary and alternate sub-cellular localizations:

  • Basolateral membrane
  • Cell junction
  • Centrosome
  • Chromosome
  • Clathrin-coated vesicle
  • Cytoplasm
  • Cytoplasmic vesicle
  • Cytoskeleton
  • Cytosol
  • Endoplasmic reticulum
  • Endosome
  • Extracellular
  • Extracellular matrix
  • Golgi apparatus
  • Lysosome
  • Microtubule
  • Mitochondrial membrane
  • Mitochondrion
  • Nuclear membrane
  • Nucleolus
  • Nucleus
  • Perinuclear region
  • Perinuclear vesicle
  • Plasma membrane
  • Secreted
  • Vesicle

Note: You are able to find and sort drugs according to target gene name, molecular function of target, and target localization from drop-down menus in the application.

Target Expression Profile

Direct links are provided from inside the application to 238 protein expression profiles of 135 drug targets in various human tissues and cancer types, cell lines and primary cells, including up to:

  • 48 different normal tissue types
  • 20 different types of cancer
  • 47 cell lines
  • 12 samples of primary blood cells

Pathway Referals

Identified targets have been cross referenced against their involvement in different cellular pathways, according to BioCarta, KEGG and NetPath.

  • BioCarta# 215 Pathways
  • KEGG# 132 Pathways
  • NetPath# 25 Signaling Pathways

Note: You are able to find and sort drugs according to targeted pathways from drop-down menus in the application.

Mechanism

In total there are different drug mechanism of action represented in this Drug Pipeline Update.

Note: You are able to find and sort drugs according to mechanism of action from drop-down menu in the application.

Compound

Identified drug compounds are described by:

Compound type, Chemical name, CAS Number and molecular weight

Note: You are able to sort and find drugs according to compound type from drop-down menu in the application.

The Drug Profiles: Progress analysis and review of drug development.

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2012 provides you with a profile for each identified drug. A typical drug profile reports on, depending on stage of development and available information:

Drug Name & Synonyms

Presentation of drug name and synonyms.

Principal Investigator & Partners

Presentation of principal investigator and partners.

Target and Molecular Function of Target

Described target(s) is/are presented with:

  • Official Gene Symbol - Official Gene Name [Species/Homo Sapiens] - Molecular Function

Target Localization

Described target(s) is/are presented with primary and alternate localizations.

Target Expression Profiles

Links to protein expression profile(s) of target(s) in various human tissues, cell lines and primary cells, including up to:

  • 48 different normal tissue types
  • 20 different types of cancer
  • 47 cell lines
  • 12 samples of primary blood cells

Targeted Pathways

Described target(s) is/are matched for the involvement in cellular pathways according to BioCarta, KEGG, and NetPath.

Mechanism

Drug mechanism of action

Developmental Projects

Summary field of developmental projects for the drug, including indication, developmental stage and status.

Example:

  • Cancer, myeloma - Phase II Clinical Trial - Active
  • Cancer, prostate - Phase III Clinical Trial - Ceased

Drug Description

Short introduction to drug.

Compound Data

Compound type, Chemical name, CAS Number and molecular weight.

Patent Data

Available patent information related to the drug is presented here.

Analysis

  • Business & Markets
  • Collaborations and deals
  • Approvals and submissions
  • Analyst comments
  • Phase III Data

Available Phase III development data, developmental history and scientific data. Phase II Data

Available Phase II development data, developmental history and scientific data. Phase I Data

Available Phase I development data, developmental history and scientific data. Preclinical Data

Available preclinical development data, developmental history and scientific data. Licensing Information

Availability for licensing.

About the unique Drug Pipeline Update Software Application After purchase, the Drug Pipeline Update is delivered to you via electronic download in a powerful yet easy to use desktop application which requires no installation.

Find and sort drugs by twelve different parameters plus free text search field. Our dynamic report generator lets you easily and quickly generate HTML drug profile reports directly in your web browser, whether it is a single drug profile or your own report selection of drugs that match your criteria.

Application Features

Use 13 different parameters, available in drop-down menus, to find and sort among drugs:

  • Drug status
  • Clinical Trial Status
  • Principle Investigator
  • Partners
  • Indication
  • Developmental Stage
  • Compound Type
  • Mechanism
  • Target
  • Molecular Function of Target
  • Target Localization
  • Targeted Pathways
  • Free text search of entire drug profile contents

Direct linkage from inside the application to related internet resources

  • Drug data is linked to search engines like Google and PubMed
  • Drug target data is linked directly to BioCarta, Human Protein Atlas, KEGG, and NetPath
  • Direct links to company web pages of principal investigators

Dynamic Report Generator Our dynamic report generator lets you with ease and speed generate html reports directly in your web browser (Internet Explorer), whether it is a single drug profile or an entire search you want have a report of. System Requirements

Operating system: Windows (2000/XP/Vista/7) and Mac OS X 10.6 (Snow Leopard) and OS X 10.7 (Lion)

  • Browser Application (Internet Explorer)
  • Internet access (to access related internet resources)

癌治療薬パイプラインにおけるB細胞受容体シグナル伝達経路」は2013年04月22日にバイオシーカー・グループより発行されました。 当レポートは税抜¥232,411より販売しています。

Back to Top